ICOS/B7RP-1 interference in mouse kidney transplantation

Transplantation

Volumn 84, Issue 2, 2007, Pages 223-230

  Lutz, Jens ^a   Lu, Ruiyan ^a,b   Strobl, Matthias ^a   Huang, Hai ^a   Deng, Meihong ^a   Wang, Minghui ^b   Ouyang, Nengtai ^a,c   Heemann, Uwe ^a,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SUN YAT SEN UNIVERSITY   (China)

^c AMERICAN HEALTH FOUNDATION   (United States)

^d Klinkum Rechts der Isar ^*  (Germany)

Author keywords

Costimulation; ICOS B7RP1; Kidney transplantation; Mouse

Indexed keywords

B7RP 1 PROTEIN; B7RP1 MONOCLONAL ANTIBODY; CD3 ANTIBODY; GAMMA INTERFERON; HYBRID PROTEIN; ICOS MONOCLONAL ANTIBODY; ICOS PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; GRAFT FAILURE; KIDNEY TRANSPLANTATION; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; T LYMPHOCYTE; TISSUE INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CD4 IMMUNOADHESINS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; IN SITU NICK-END LABELING; INTRACELLULAR FLUID; KIDNEY TRANSPLANTATION; LIGANDS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 34547615901     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000267439.15439.61     Document Type: Article

References (26)

1. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
2. Azuma H, Chandraker A, Nadeau K. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A 1996; 93: 12439.
3. Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J Immunol 1999; 162: 1947.
4. Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402: 827.
5. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23: 515.
6. Özkaynak E, Gao W, Shemmeri N, et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001; 2: 591.
7. Guillonneau C, Aubry V, Renaudin K, et al. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation 2005; 80: 546.
8. Kashizuka H, Sho M, Nomi T, et al. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. Transplantation 2005; 79: 1045.
9. Grimbacher B, Warnatz K, Peter HH. The immunological synapse for B-cell memory: The role of the ICOS and its ligand for the longevity of humoral immunity. Curr Opin Allergy Clin Immunol 2003; 3: 409.
10. Iwai H, Abe M, Hirose S, et al. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol 2003; 171: 2848.
11. Wahl P, Schoop R, Bilic G, et al. Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol 2002; 13: 1517.
12. Wahl P, Wuthrich RP. Role of the B7RP-1/ICOS pathway in renal tubular epithelial antigen presentation to CD4+ Th1 and Th2 cells. Nephron Exp Nephrol 2004; 98: e31.
13. Klingenberg R, Autschbach F, Gleissner C, et al. Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro. Eur J Immunol 2005; 35: 1712.
14. Beier KC, Hutloff A, Dittrich AM, et al. Induction, binding specificity and function of human ICOS. Eur J Immunol 2000; 30: 3707.
15. Sporici RA, Beswick RL, von Allmen C, et al. ICOS ligand costimulation is required for T-cell encephalitogenicity. Clin Immunol 2001; 100: 277.
16. Ara G, Baher A, Storm M, et al. Potent activity of soluble B7RP-1-FC in therapy of murine tumors in syngenic hosts. Int J Cancer 2003; 103: 501.
17. Lutz J, Zou H, Liu S, Antus B, Heemann U. Apoptosis and treatment of chronic allograft nephropathy with everolimus. Transplantation 2003; 76: 508.
18. Nurieva RI, Mai XM, Forbush K, Bevan MJ, Dong C. B7h is required for T cell activation, differentiation, and effector function. Proc Natl Acad Sci U S A 2003; 100: 14163.
19. Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducuble costimulator structurally and functionally related to CD28. Nature 1999; 397: 263.
20. de Haij S, Woltman AM, Trouw LA, et al. Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1. Kidney Int 2005; 68: 2091.
21. Rottman JB, Smith T, Tonra JR, et al. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol 2001; 2: 605.
22. Harada H, Salama AD, Sho M, et al. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 2003; 112: 234.
23. Nanji SA, Hancock WW, Anderson CC, et al. Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival. Transpl Proc 2003; 35: 2477.
24. Nanji SA, Hancock WW, Anderson CC, et al. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transpl 2004; 4: 526.
25. Carreno BM, Collins M. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29.
26. Vieira PL, Wassink L, Smith LM, et al. ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cells. Eur J Immunol 2004; 34: 1282.